[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BR9911679A - Paroxetine salts - Google Patents

Paroxetine salts

Info

Publication number
BR9911679A
BR9911679A BR9911679-0A BR9911679A BR9911679A BR 9911679 A BR9911679 A BR 9911679A BR 9911679 A BR9911679 A BR 9911679A BR 9911679 A BR9911679 A BR 9911679A
Authority
BR
Brazil
Prior art keywords
paroxetine salts
paroxetine
salts
therapy
preparing
Prior art date
Application number
BR9911679-0A
Other languages
Portuguese (pt)
Inventor
Victor Witold Jacewicz
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BR9911679A publication Critical patent/BR9911679A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)

Abstract

"SAIS DE PAROXETINA". São revelados compostos de piperidina, processos para preparação dos mesmos, composições farmacêuticas contendo os mesmos e sua utilização na terapia."PAROXETINE SALTS". Piperidine compounds, processes for preparing them, pharmaceutical compositions containing them and their use in therapy are disclosed.

BR9911679-0A 1998-07-02 1999-06-30 Paroxetine salts BR9911679A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9814316.7A GB9814316D0 (en) 1998-07-02 1998-07-02 Novel compounds
PCT/EP1999/004543 WO2000001692A1 (en) 1998-07-02 1999-06-30 Salts of paroxetine

Publications (1)

Publication Number Publication Date
BR9911679A true BR9911679A (en) 2002-01-29

Family

ID=10834803

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9911679-0A BR9911679A (en) 1998-07-02 1999-06-30 Paroxetine salts

Country Status (21)

Country Link
EP (1) EP1091958A1 (en)
JP (1) JP2002519421A (en)
KR (1) KR20010053337A (en)
CN (1) CN1314906A (en)
AP (1) AP2000002017A0 (en)
AU (2) AU4903999A (en)
BG (1) BG105204A (en)
BR (1) BR9911679A (en)
CA (1) CA2336470A1 (en)
CZ (1) CZ20004923A3 (en)
EA (1) EA200100098A1 (en)
GB (1) GB9814316D0 (en)
HU (1) HUP0103712A3 (en)
ID (1) ID27766A (en)
IL (1) IL140385A0 (en)
NO (1) NO20006547L (en)
PL (1) PL345365A1 (en)
SK (1) SK20242000A3 (en)
TR (1) TR200100055T2 (en)
WO (1) WO2000001692A1 (en)
ZA (2) ZA992899B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1745791B1 (en) 2003-05-07 2013-06-26 Osteologix A/S Treating cartilage/bone conditions with water-soluble strontium salts
SI2266584T1 (en) 2003-05-07 2012-12-31 Osteologix A/S, Symbion Composition with strontium and vitamin D for the prophylaxis and/or treatment of cartilage and/or bone conditions
AU2005216596B2 (en) 2004-02-26 2011-03-24 Osteologix A/S Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions
EP1744770A2 (en) 2004-05-06 2007-01-24 Osteologix A/S High yield and rapid syntheses methods for producing metallo-organic salts
KR100672184B1 (en) 2004-09-21 2007-01-19 주식회사종근당 Paroxetine cholate or cholic acid derivative salts
WO2008014430A1 (en) * 2006-07-27 2008-01-31 Emisphere Technologies, Inc. Arylsulfanyl compounds and compositions for delivering active agents
CN109212055B (en) * 2018-08-19 2021-05-07 丁立平 Gas chromatography-mass spectrometry combined method for determining four trace monohalogenated phenylacetic acids in drinking water
CN109342633B (en) * 2018-11-27 2020-10-02 北京市化工职业病防治院 Method for detecting metabolites of benzene, toluene and xylene in urine
CN111337460B (en) * 2018-12-18 2021-09-17 中国科学院大连化学物理研究所 High-stability Halo-tag probe and synthesis and biological application thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride
HU221921B1 (en) * 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzyl-piperidine or tetrahydro-pyridine derivatives and processes for producing them
KR100543614B1 (en) * 1997-06-10 2006-01-20 신톤 비.브이. 4-phenylpiperidine compounds
SK11812000A3 (en) * 1998-02-06 2001-08-06 Smithkline Beecham Plc Salts of paroxetine

Also Published As

Publication number Publication date
JP2002519421A (en) 2002-07-02
ZA992899B (en) 2000-03-29
CN1314906A (en) 2001-09-26
TR200100055T2 (en) 2001-07-23
HUP0103712A3 (en) 2002-09-30
GB9814316D0 (en) 1998-09-02
IL140385A0 (en) 2002-02-10
AU4903999A (en) 2000-01-24
AP2000002017A0 (en) 2000-12-31
AU2002100370A4 (en) 2002-06-06
ID27766A (en) 2001-04-26
NO20006547D0 (en) 2000-12-21
CA2336470A1 (en) 2000-01-13
CZ20004923A3 (en) 2001-08-15
PL345365A1 (en) 2001-12-17
SK20242000A3 (en) 2001-07-10
ZA200100020B (en) 2002-03-25
EP1091958A1 (en) 2001-04-18
NO20006547L (en) 2001-02-12
HUP0103712A2 (en) 2002-05-29
EA200100098A1 (en) 2001-08-27
WO2000001692A1 (en) 2000-01-13
BG105204A (en) 2001-11-30
KR20010053337A (en) 2001-06-25

Similar Documents

Publication Publication Date Title
DK199900554A (en) Paroxetine salts, process for their preparation, pharmaceutical compositions comprising these and uses thereof
EE04399B1 (en) Spiroazabicyclic Heterocyclic Compounds, Process for their Preparation, Pharmaceutical Compositions Containing Them and Their Use in Therapy
NO20002787L (en) New connections
SE9704544D0 (en) Novel compounds
BR0016543A (en) New piperidine and piperazine derivatives
FI973279A (en) Novel farnesyltransferase inhibitors, their preparation and pharmaceutical compositions containing them
NO973922L (en) New taxoids, their preparation and pharmaceutical compositions containing the compounds
DK0760661T3 (en) Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use in the treatment of endorphin m
NO20002785D0 (en) Adam Anta Derivatives
ATE345133T1 (en) LACTOSE-FREE, NON-HYGROSCOPIC AND ANHYDROUS PHARMACEUTICAL COMPOSITIONS OF DESCARBOETHOXYLORATADINE
PT839041E (en) The invention relates to a process for preparing a medicament for the preparation of a medicament for the preparation of a medicament for the preparation of a medicament for the preparation of a medicament for the preparation of a medicament for the preparation of medicaments.
SE9802208D0 (en) Novel compounds
BR9801150A (en) Propanolamine derivatives, processes for preparing them, pharmaceutical products comprising these compounds and their use.
IS5851A (en) New Oral 5-HT4 Agents or Antagonists
BR9911679A (en) Paroxetine salts
EE04346B1 (en) Azoles, process for their preparation, use and pharmaceutical composition
BR9611642A (en) Pharmaceutical composition compounds and process for the preparation of compounds
BR9705456A (en) Heterocyclic compounds, aminomethyl process for their preparation and pharmaceutical compositions that contain them.
EE03996B1 (en) Pharmaceutical compositions, process for their preparation and use
BR0318659A (en) proline derivatives used as active pharmaceutical ingredients in the treatment of tumors
SE9802209D0 (en) Novel compounds
PT1017681E (en) PHARMACEUTICAL AND INTERMEDIATE COMPOUNDS
BR9802803A (en) action and pharmaceutical compositions containing them.
NO974057D0 (en) Bisyclic tachykinin antagonists, their preparation and their use in pharmaceutical composition
IT1290910B1 (en) 2-OPTICALLY ACTIVE AMINOTETRALINE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT, ACTIVE

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]